(NASDAQ: SNOA) Sonoma Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 43.31%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.08%.
Sonoma Pharmaceuticals's earnings in 2025 is -$3,457,000.On average, 1 Wall Street analyst forecast SNOA's earnings for 2026 to be -$2,168,450, with the lowest SNOA earnings forecast at -$2,168,450, and the highest SNOA earnings forecast at -$2,168,450.
In 2027, SNOA is forecast to generate -$739,244 in earnings, with the lowest earnings forecast at -$739,244 and the highest earnings forecast at -$739,244.